Comparison of Target- and IgG-Enrichment Strategies to Measure Adalimumab Concentrations in Human Plasma Using an Immunocapture-Liquid Chromatography-High-Resolution Mass Spectrometry Platform.

Ding, Xiaoliang; Zhu, Shengxiong; Liu, Linsheng; Liu, Xiaoxue; Zhu, Kouzhu; Miao, Liyan

Ding, Xiaoliang; Zhu, Shengxiong; Liu, Linsheng; Liu, Xiaoxue; Zhu, Kouzhu; Miao, Liyan.

Afiliação

Ding X; Department of Pharmacy, The First Affiliated Hospital of Soochow University, Suzhou, China.
Zhu S; Institute for Interdisciplinary Drug Research and Translational Sciences, Soochow University, Suzhou, China.
Liu L; Department of Pharmacy, The First Affiliated Hospital of Soochow University, Suzhou, China.
Liu X; Institute for Interdisciplinary Drug Research and Translational Sciences, Soochow University, Suzhou, China.
Zhu K; Department of Pharmacy, The First Affiliated Hospital of Soochow University, Suzhou, China.
Miao L; Institute for Interdisciplinary Drug Research and Translational Sciences, Soochow University, Suzhou, China.

Ann Lab Med ; 44(5): 463-466, 2024 Sep 01.

Article em En | MEDLINE | ID: mdl-38589211

Assuntos

Adalimumab; Imunoglobulina G; Humanos; Adalimumab/sangue; Cromatografia Líquida/métodos; Imunoglobulina G/sangue; Espectrometria de Massas/métodos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoglobulina G / Adalimumab Limite: Humans Idioma: En Revista: Ann Lab Med Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China País de publicação: Coréia do Sul

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google